oncology

1,857 projects

H2020Individual fellowship2015–2017Germany

IMPAM · Development of a new immunoassay platform based on porous antibody microparticles

H2020Doctoral network2015–2019Germany

IMMUTRAIN · Training Network for the Immunotherapy of Cancer

10 partners · 8 countries

H2020Doctoral network2015–2019United Kingdom

MELGEN · MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival

6 partners · 5 countries

H2020Individual fellowship2015–2018Netherlands

PREVENT · Prostate cancer extracellular vesicles as biomarkers for nanomedicine treatment

2 partners · 2 countries

H2020Doctoral network2015–2019Netherlands

VIRION · Viruses, Immune stimulation and RNA Interference in Oncology Network

9 partners · 4 countries

H2020Individual fellowship2015–2017Italy

NANOTAM · Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages

H2020Staff exchange2015–2019Portugal

INPACT · Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.

10 partners · 5 countries

H2020Doctoral network2015–2019Switzerland

MEDICIS-PROMED · MEDICIS-produced radioisotope beams for medicine

15 partners · 8 countries

H2020Individual fellowship2015–2017Netherlands

Evolutionary Neurogenomics · The impact of recent retrotransposon invasions on the evolution of human neural gene expression

H2020Individual fellowship2015–2018Netherlands

CARDIOTOX · Predicting Cardiotoxicity Induced by Kinase Inhibitors: From Systems Biology to Systems Pharmacology

2 partners · 2 countries

H2020Individual fellowship2015–2017Denmark

HepatoRiSK · A new tumor suppressor role for RSK2 in hepatocellular carcinoma

H2020Individual fellowship2015–2017France

CHAT · Control of the Homeostasis of Actin through Time: actin homeostasis during embryonic development by means of single-molecule imaging and simulation in C. elegans

2 partners

H2020Individual fellowship2015–2017United Kingdom

BRCA2Interact · Structural and biochemical characterization of pre-recombination complexes

2 partners

H2020Individual fellowship2015–2017France

TITLY · Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma

2 partners · 2 countries

H2020Individual fellowship2015–2018France

LYMPHOSIGN · Integrated study of the role of B-cell receptor signaling in the development of Follicular Lymphoma

2 partners · 2 countries

H2020Individual fellowship2015–2017Spain

RLOOP-AS · Interconnection between R-loops and co-transcriptional alternative splicing

H2020Individual fellowship2015–2017Germany

TransVivome · Microbial biogeography of the gastrointestinal tract: Towards a better understanding of the drivers of oral and colorectal cancer development.

H2020Individual fellowship2015–2017Denmark

PIOMES · Pbx proteins as pioneer factors promoting signal specificity in mesodermal differentiation

H2020Individual fellowship2015–2017Germany

APOBEC · Enzymatic DNA deamination and the immunity/cancer balance

H2020Individual fellowship2015–2017France

Lx Micelles · Coordination chemistry in doubly stabilized micelles for the tageted delivery of cytostatic drugs in cancer therapy

H2020Individual fellowship2015–2017United Kingdom

SFSASP · Structural and Functional Studies of ATRX- Syndrome Protein

H2020Individual fellowship2015–2017Germany

EGFR-Activ · Epidermal growth factor receptor (EGFR) activation by cytohesins - Structural Insights

H2020Individual fellowship2015–2018Germany

ISPADMEC · Integrin specificity in rigidity sensitive proliferation, activation and directional migration of endothelial cells

H2020Individual fellowship2015–2017Spain

ACM · Cholesterol metabolism as a driver of prostate cancer aggressiveness